Prognostic value of decline in model for end-stage liver disease score and hepatic encephalopathy in hepatitis B-related acute-on-chronic liver failure patients treated with plasma exchange

References

• Gish RG, Given BD, Lai CL, Locarnini SA, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014. Hepatol Int. 2014;8(4):453–471.
   PubMed Web of Science ®Google Scholar
• Arroyo V, Moreau R, Jalan R. Acute-on-chronic liver failure. N Engl J Med. 2020;382(22):2137–2145.
   PubMed Web of Science ®Google Scholar
• You S, Rong Y, Zhu B, et al. Changing etiology of liver failure in 3,916 patients from Northern China: a 10-year survey. Hepatol Int. 2013;7(2):714–720.
   PubMed Web of Science ®Google Scholar
• Ocskay K, Kanjo A, Gede N, et.al. Uncertainty in the impact of liver support systems in acute-on-chronic liver failure: a systematic review and network meta-analysis. Ann Intensive Care. 2021;11(1):10.
   PubMed Web of Science ®Google Scholar
• Tan EX, Wang MX, Pang J, et al. Plasma exchange in patients with acute and acute-on-chronic liver failure: a systematic review. WJG. 2020;26(2):219–245.
   PubMed Web of Science ®Google Scholar
• Choe W, Kwon SW, Kim SS, et al. Effects of therapeutic plasma exchange on early allograft dysfunction after liver transplantation. J Clin Apheresis. 2017;32(3):147–153.
   PubMed Web of Science ®Google Scholar
• Hetz H, Faybik P, Berlakovich G, et al. Molecular adsorbent recirculating system in patients with early allograft dysfunction after liver transplantation: a pilot study. Liver Transpl. 2006;12(9):1357–1364.
   PubMed Web of Science ®Google Scholar
• Li J, Liang X, You S, et al. Chinese group on the study of severe hepatitis B (COSSH). development and validation of a new prognostic score for hepatitis B virus-related acute-on-chronic liver failure. J Hepatol. 2021;75(5):1104–1115.
   PubMed Web of Science ®Google Scholar
• Chinese society of hepatol. The guideline of prevention and treatment of chronic hepatitis B: a 2015 update. Chin J Hepatol. 2015;31(12):1941–1960.
   Google Scholar
• Wu T, Li J, Shao L, et al. Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure. Gut. 2018;67(12):2181–2191.
   PubMed Web of Science ®Google Scholar
• Asrani SK, Kim WR. Model for end-stage liver disease: end of the first decade. Clin Liver Dis. 2011;15(4):685–698.
   PubMed Web of Science ®Google Scholar
• Moreau R, Jalan R, Gines P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144(7):1426–1437.
   PubMed Web of Science ®Google Scholar
• Wlodzimirow KA, Eslami S, Abu-Hanna A, et al. A systematic review on prognostic indicators of acute on chronic liver failure and their predictive value for mortality. Liver Int. 2013;33(1):40–52.
   PubMed Web of Science ®Google Scholar
• Yang L, Wu T, Li J, et al. Artificial liver treatment improves survival in patients with hepatitis B virus-related acute-on-chronic liver failure: a case-control matched analysis. Hepatol Res. 2020;50(6):656–670.
   PubMed Web of Science ®Google Scholar
• Maiwall R, Bajpai M, Choudhury AK, et al. At al; AARC working party. Therapeutic plasma-exchange improves systemic inflammation and survival in acute-on-chronic liver failure: a propensity-score matched study from AARC. Liver Int. 2021 May;41(5):1083–1096.
   PubMed Web of Science ®Google Scholar
• Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31(4):864–871.
   PubMed Web of Science ®Google Scholar
• Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease score and allocation of donor livers. Gastroenterology. 2003;124(1):91–96.
   PubMed Web of Science ®Google Scholar
• Sharma P, Schaubel DE, Gong Q, et al. End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates. Hepatology. 2012;55(1):192–198.
   PubMed Web of Science ®Google Scholar
• Lopes-Secundo TM, Sevá-Pereira T, Correa BR, et al. Serum sodium, model for end-stage liver disease, and a recent invasive procedure are risk factors for severe acute-on-chronic liver failure and death in cirrhotic patients hospitalized with bacterial infection. Eur J Gastroenterol Hepatol. 2018;30(9):1055–1059.
   PubMed Web of Science ®Google Scholar
• Yao YH, Zhao WF, Gan JH. Model for end-stage liver disease combined with arterial blood lactate to assess the prognosis of hepatitis B virus-associated acute-on-chronic liver failure: a retrospective analysis of 97 cases. Zhonghua Gan Zang Bing Za Zhi. 2019;27(4):256–260.
   PubMedGoogle Scholar
• Goudsmit BFJ, Tushuizen ME, Putter H, et al. The role of the model for end-stage liver disease-sodium score and joint models for 90-day mortality prediction in patients with acute-on-chronic liver failure. J Hepatol. 2021;74(2):475–476.
   PubMed Web of Science ®Google Scholar
• Yu JW, Sun LJ, Zhao YH, et al. Prediction value of model for end-stage liver disease scoring system on prognosis in patients with acute-on-chronic hepatitis B liver failure after plasma exchange and lamivudine treatment. J Gastroenterol Hepatol. 2008;23(8pt1):1242–1249.
   PubMedGoogle Scholar
• Ling Q, Xu X, Wei Q, et al. Downgrading MELD improves the outcomes after liver transplantation in patients with acute-on-chronic hepatitis B liver failure. PLOS One. 2012;7(1):e30322.
   PubMed Web of Science ®Google Scholar
• Huang K, Ji F, Xie Z, et al. Artificial liver support system therapy in acute-on-chronic hepatitis B liver failure: classification and regression tree analysis. Sci Rep. 2019;9(1):16462.
   PubMed Web of Science ®Google Scholar
• Du L, Ma Y, Zhou S, et al. A prognostic score for patients with acute-on-chronic liver failure treated with plasma exchange-centered artificial liver support system. Sci Rep. 2021;11(1):1469.
   PubMed Web of Science ®Google Scholar
• Liver Failure and Artificial Liver Group, Branch of Infectious Diseases, Chinese Medical Association. Guideline for non-bioartificial liver support systems in treatment of liver failure. Chin J Clin Infect Dis. 2016;9(02):97–10.
   Google Scholar